Skip to main content
SpringerLink
Log in

Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Using monolayers of human pancreatic adenocarcinoma cells (Panc-1) that express multidrug resistance-associated protein (MRP), the present work investigates the effects of Pluronic block copolymers on the functional activity of MRP.

Methods. The studies examined the accumulation and efflux of the MRP selective probe fluorescein (FLU) in Panc-1 cell monolayers with and without Pluronic P85 (P85), Pluronic L81 (L81) and Pluronic F108 (F108).

Results. Treatment of Panc-1 cells with P85 resulted in concentration-dependent increases in FLU accumulation and elimination of FLU sequestration in vesicular compartments in these cells. The effects of P85 were selective for FLU in the Panc-1 cell monolayers. Inhibition of MRP-mediated transport was dependent on the composition of Pluronic block copolymer: the more hydrophobic copolymer had the greater effect on FLU uptake in Panc-1 monolayers (L81 > P85 > F108).

Conclusions. This paper demonstrates for the first time that Pluronic block copolymers inhibit multidrug resistance-associated protein (MRP). The similarities in the effects of Pluronic block copolymers on MRP and P-glycoprotein drug efflux systems suggest that a single unifying mechanism may explain the inhibition observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. Krishan, C. M. Fitz, and I. Andritsch. Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279-285 (1997).

    Google Scholar 

  2. H. W. Van Veen and W. N. Konings. Multidrug transport from bacteria to man: similarities in structure and function. Semin. Cancer Biol. 8:183-191 (1997).

    Google Scholar 

  3. P. G. Bray and S. A. Ward. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in plasmodium falciparum. Pharmacol. Ther. 77:1-28 (1998).

    Google Scholar 

  4. U. A. Germann, I. Pastan, and M. M. Gottesman. p-Glycoproteins: mediators of multidrug resistance. Semin. Cell. Biol. 4:63-76 (1993).

    Google Scholar 

  5. A. H. Schinkel, J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdr-1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).

    Google Scholar 

  6. V. Y. Alakhov, E. Y. Moskaleva, E. V. Batrakova, and A. V. Kabanov. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjugate Chem. 7:209-216 (1996).

    Google Scholar 

  7. A. Venne, S. Li, R. Mandeville, A. V. Kabanov, and V. Y. Alakhov. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 56:3626-3629 (1996).

    Google Scholar 

  8. D. W. Miller, E. V. Batrakova, T. O. Waltner, V. Y. Alakhov, and A. V. Kabanov. Interactions of Pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chem. 8:649-657 (1997).

    Google Scholar 

  9. M. A. Barrand, T. Bagrij, and S. Y. Neo. Multidrug resistance-associated protein: a protein disinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen. Pharmacol. 28:639-645 (1997).

    Google Scholar 

  10. Z. Hollo, L. Homolya, T. Hegedus, and B. Sarkadi. Transport properties of the multidrug resistance-associated protein (MRP) in human tumor cells. FEBS Lett. 383, 99-104 (1996).

    Google Scholar 

  11. G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler. Transport of glutatione, glucuronate, and sulfate conjugates by the MRP gene-encoded export pump. Cancer Res. 56:988-994 (1996).

    Google Scholar 

  12. M. J. Flens, G. J. Zaman, P. van-der-Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van-der-Groep, M. de-Haas, C. J. Meijer, R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247 (1996).

    Google Scholar 

  13. D. W. Miller, M. Fontaine, C. Kolar, T. Lawson. The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett. 107:301-306 (1996).

    Google Scholar 

  14. H. Huai-Yun, D. T. Secrest, K. S. Mark, D. Carney, C. Brandquist, W. F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Com. 243: 816-820 (1998).

    Google Scholar 

  15. M. P. Draper, R. L. Martell, and S. B. Levy. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br. J. Cancer 75:810-815 (1997).

    Google Scholar 

  16. M. Fontaine, W. F. Elmquist, and D. W. Miller. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci. 59:1521-1531 (1996).

    Google Scholar 

  17. E. V. Batrakova, H.-Y. Han, V. Yu. Alakhov, D. W. Miller, and A. V. Kabanov. Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 15:850-855 (1998).

    Google Scholar 

  18. K. Nooter and G. Stoter. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192:768-780 (1996).

    Google Scholar 

  19. L. M. Breuninger, S. Paul, K. Gaughan, T. Miki, A. Chan, S. A. Aaronson, and G. D. Kruh. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer. Res. 55:5342-5347 (1995).

    Google Scholar 

  20. I. Cleary, G. Doherty, E. Moran, and M. Clynes. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol. 53:1493-1502 (1997).

    Google Scholar 

  21. P. R. Twentyman. Transport proteins in drug resistance: biology and approaches to circumvention. J. Intern. Med. Suppl. 740:133-137 (1997).

    Google Scholar 

  22. A. B. Shapiro, K. Fox, P. Lee, Y. D. Yang, and V. F. Ling. Functional intracellular P-glycoprotein. Int. J. Cancer 76:857-864 (1998).

    Google Scholar 

  23. Y. Abe, Y. Ohnishi, M. Yoshimura, E. Ota, Y. Ozeki, Y. Oshika, T. Tokunaga, H. Yamazaki, Y. Ueyema, T. Ogata, N. Tamaoki, and M. Nakamura. P-Glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br. J. Cancer 74:1929-1934 (1996).

    Google Scholar 

  24. G. D. Kruh, K. T. Gaughan, A. Godwin, and A. Chan. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. 87:1256-1258 (1995).

    Google Scholar 

  25. M. J. Flens, G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Phathol. 148:1237-1247 (1996).

    Google Scholar 

  26. B. D. Stride, G. Valdimarsson, J. H. Gerlach, G. M. Wilson, S. P. Cole, and R. G. Deeley. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971 (1996).

    Google Scholar 

  27. E. V. Batrakova, T. Yu. Dorodnych, E. Yu. Klinskii, E. N. Kliushnenkova, O. B. Shemchukova, S. A. Arjakov, V. Yu. Alakhov, A. V. Kabanov. Anthracycline antibiotics non-covalently incorporated into the block-copolymer micelles: in vivo evaluation of anticancer activity. Br. J. Cancer 74:1545-1552 (1996).

    Google Scholar 

  28. V. Yu. Alakhov, A. V. Kabanov. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Op. Invest. Drugs 7:1453-1473 (1998).

    Google Scholar 

  29. E. V. Batrakova, H-Y. Han, D. W. Miller, A. V. Kabanov. Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15:1525-1532 (1998).

    Google Scholar 

  30. R. B. Kim, M. F. Fromm, C. Wandel, B. Leake, A. J. J. Wood, D. M. Roden, and G. R. Wilkinson. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101:289-294 (1998).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 600 S. 42nd St., Omaha, Nebraska, 68198-6025

    Donald W. Miller, Elena V. Batrakova & Alexander V. Kabanov

Authors
  1. Donald W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena V. Batrakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander V. Kabanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander V. Kabanov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, D.W., Batrakova, E.V. & Kabanov, A.V. Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers. Pharm Res 16, 396–401 (1999). https://doi.org/10.1023/A:1018873702411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018873702411

Search

Navigation